On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions.
Javier PuenteFernando GascónBorja PonteDavid de la FuentePublished in: Artif. Intell. Medicine (2019)
Keyphrases
- case study
- minimum risk
- knowledge management
- decision making
- fuzzy sets
- fuzzy logic
- fuzzy numbers
- sufficient conditions
- risk management
- membership functions
- fuzzy clustering
- soft computing
- risk assessment
- expert systems
- fuzzy neural network
- knowledge base
- design choices
- organizational structure
- competitive environment
- artificial intelligence